LHC Group, Inc. (LHCG) Stake Lessened by Wasatch Advisors Inc.

Wasatch Advisors Inc. decreased its holdings in LHC Group, Inc. (NASDAQ:LHCG) by 7.9% in the 1st quarter, HoldingsChannel reports. The firm owned 176,624 shares of the health services provider’s stock after selling 15,238 shares during the quarter. Wasatch Advisors Inc.’s holdings in LHC Group were worth $19,581,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. Citigroup Inc. grew its stake in shares of LHC Group by 265.2% in the fourth quarter. Citigroup Inc. now owns 4,386 shares of the health services provider’s stock worth $412,000 after purchasing an additional 3,185 shares in the last quarter. Everence Capital Management Inc. grew its stake in shares of LHC Group by 43.6% in the first quarter. Everence Capital Management Inc. now owns 4,050 shares of the health services provider’s stock worth $449,000 after purchasing an additional 1,230 shares in the last quarter. Eqis Capital Management Inc. grew its stake in shares of LHC Group by 6.2% in the fourth quarter. Eqis Capital Management Inc. now owns 4,837 shares of the health services provider’s stock worth $454,000 after purchasing an additional 281 shares in the last quarter. Campbell Newman Asset Management Inc. grew its stake in shares of LHC Group by 2.4% in the first quarter. Campbell Newman Asset Management Inc. now owns 6,350 shares of the health services provider’s stock worth $704,000 after purchasing an additional 151 shares in the last quarter. Finally, Financial Gravity Companies Inc. bought a new position in shares of LHC Group in the fourth quarter worth $49,000. 93.88% of the stock is owned by institutional investors.

In other news, COO Donald Dwayne Stelly sold 448 shares of LHC Group stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $120.00, for a total transaction of $53,760.00. Following the sale, the chief operating officer now owns 91,252 shares of the company’s stock, valued at approximately $10,950,240. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Ronald T. Nixon sold 12,000 shares of LHC Group stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $117.20, for a total value of $1,406,400.00. Following the sale, the director now directly owns 29,100 shares in the company, valued at approximately $3,410,520. The disclosure for this sale can be found here. Insiders sold a total of 130,324 shares of company stock worth $14,222,700 in the last ninety days. Insiders own 5.20% of the company’s stock.

Several research analysts have recently issued reports on the company. Zacks Investment Research cut LHC Group from a “hold” rating to a “sell” rating in a research note on Thursday, May 2nd. UBS Group set a $133.00 target price on LHC Group and gave the company a “buy” rating in a research note on Friday, May 10th. BidaskClub raised LHC Group from a “buy” rating to a “strong-buy” rating in a research note on Friday, May 17th. Barclays raised their target price on LHC Group from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Thursday, March 21st. Finally, Jefferies Financial Group raised their target price on LHC Group from $125.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, May 9th. Four analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. LHC Group currently has a consensus rating of “Buy” and a consensus target price of $118.50.

LHCG traded down $1.78 during midday trading on Thursday, reaching $117.09. The company’s stock had a trading volume of 124,600 shares, compared to its average volume of 253,604. The firm has a market capitalization of $3.74 billion, a P/E ratio of 32.98, a price-to-earnings-growth ratio of 2.02 and a beta of 0.87. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.21. LHC Group, Inc. has a twelve month low of $73.21 and a twelve month high of $122.20.

LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, May 8th. The health services provider reported $0.98 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.08. The firm had revenue of $502.59 million for the quarter, compared to analyst estimates of $511.16 million. LHC Group had a return on equity of 8.43% and a net margin of 3.83%. As a group, analysts anticipate that LHC Group, Inc. will post 4.3 earnings per share for the current year.

WARNING: This article was originally posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/05/23/lhc-group-inc-lhcg-stake-lessened-by-wasatch-advisors-inc.html.

LHC Group Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Featured Story: How do CD ladders protect against rising interest rates?

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.